Bone marrow involvement of Langerhans cell histiocytosis: Immunohistochemical evaluation of bone marrow for CD1a, Langerin, and S100 expression

Histopathology

Volumn 65, Issue 6, 2014, Pages 742-748

  Kim, Hyun Ki ^a   Park, Chan Jeoung ^a   Jang, Seongsoo ^a   Cho, Young Uk ^a   Park, Sang Hyuk ^b   Koh, Kyung Nam ^a   Im, Ho Joon ^a   Seo, Jong Jin ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Bone marrow; Immunohistochemical stain; Langerhans cell histiocytosis; Langerin

Indexed keywords

LANGERIN; PROTEIN S 100; T6 ANTIGEN; BIOLOGICAL MARKER; CD1 ANTIGEN; CD207 PROTEIN, HUMAN; LECTIN; LEUKOCYTE ANTIGEN; MANNOSE BINDING LECTIN;

ADULT; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; BONE MARROW DISEASE; CELL COUNT; CONTROLLED STUDY; CYTOPENIA; ERYTHROPHAGOCYTOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LANGERHANS CELL HISTIOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TISSUE SECTION; ADOLESCENT; BIOSYNTHESIS; CHILD; DISEASE FREE SURVIVAL; INFANT; MORTALITY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, CD1; BIOLOGICAL MARKERS; BONE MARROW; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; LECTINS, C-TYPE; MALE; MANNOSE-BINDING LECTINS; RETROSPECTIVE STUDIES; S100 PROTEINS; YOUNG ADULT;

EID: 84919435628     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12481     Document Type: Article

References (22)

1. Jaffe R, Weiss LM, Facchetti F. Tumours derived from Langerhans cells. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW ed. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: International Agency for Research on Cancer, 2008; 358-360.
2. Abla O, Egeler RM, Weitzman S. Langerhans cell histiocytosis: current concepts and treatments. Cancer Treat. Rev. 2010; 36; 354-359.
3. Badalian-Very G, Vergilio JA, Fleming M, Rollins BJ. Pathogenesis of Langerhans cell histiocytosis. Annu. Rev. Pathol. 2013; 8; 1-20.
4. Galluzzo ML, Braier J, Rosenzweig SD, Garcia de Davila MT, Rosso D. Bone marrow findings at diagnosis in patients with multisystem langerhans cell histiocytosis. Pediatr. Dev. Pathol. 2010; 13; 101-106.
5. Minkov M, Potschger U, Grois N, Gadner H, Dworzak MN. Bone marrow assessment in Langerhans cell histiocytosis. Pediatr. Blood Cancer 2007; 49; 694-698.
6. McClain K, Ramsay NK, Robison L, Sundberg RD, Nesbit M Jr. Bone marrow involvement in histiocytosis X. Med. Pediatr. Oncol. 1983; 11; 167-171.
7. Gadner H, Grois N, Potschger U et al. Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 2008; 111; 2556-2562.
8. Maria Postini A, del Prever AB, Pagano M et al. Langerhans cell histiocytosis: 40 years' experience. J. Pediatr. Hematol. Oncol. 2012; 34; 353-358.
9. Minkov M, Grois N, Heitger A et al. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Med. Pediatr. Oncol. 2002; 39; 581-585.
10. Lee JW, Shin HY, Kang HJ et al. Clinical characteristics and treatment outcome of langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center. Pediatr. Hematol. Oncol. 2014; 31; 293-302.
11. Badalian-Very G, Vergilio JA, Degar BA, Rodriguez-Galindo C, Rollins BJ. Recent advances in the understanding of Langerhans cell histiocytosis. Br. J. Haematol. 2012; 156; 163-172.
12. Sholl LM, Hornick JL, Pinkus JL, Pinkus GS, Padera RF. Immunohistochemical analysis of Langerin in Langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases. Am. J. Surg. Pathol. 2007; 31; 947-952.
13. Lau SK, Chu PG, Weiss LM. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am. J. Surg. Pathol. 2008; 32; 615-619.
14. Dziegiel P, Dolilnska-Krajewska B, Dumanska M et al. Coexpression of CD1a, langerin and Birbeck's granules in Langerhans cell histiocytoses (LCH) in children: ultrastructural and immunocytochemical studies. Folia Histochem. Cytobiol. 2007; 45; 21-25.
15. Pileri SA, Grogan TM, Harris NL et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002; 41; 1-29.
16. Goel S, Polski JM, Imran H. Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis. Ann. Clin. Lab. Sci. 2012; 42; 21-25.
17. Gupta A, Tyrrell P, Valani R, Benseler S, Weitzman S, Abdelhaleem M. The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 2008; 51; 402-404.
18. Takahashi K, Isobe T, Ohtsuki Y, Sonobe H, Takeda I, Akagi T. Immunohistochemical localization and distribution of S-100 proteins in the human lymphoreticular system. Am. J. Pathol. 1984; 116; 497-503.
19. Romani N, Clausen BE, Stoitzner P. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol. Rev. 2010; 234; 120-141.
20. Idoyaga J, Suda N, Suda K, Park CG, Steinman RM. Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen. Proc. Natl Acad. Sci. USA 2009; 106; 1524-1529.
21. Seguier S, Bodineau A, Godeau G, Pellat B, Brousse N. Langerin+ versus CD1a+ Langerhans cells in human gingival tissue: a comparative and quantitative immunohistochemical study. Arch. Oral Biol. 2003; 48; 255-262.
22. Won D, Park CJ, Shim H et al. Subtle CD20 positivity in the bone marrow of a patient who has a mucosa-associated lymphoid tissue lymphoma should not be regarded as evidence of involvement in the bone marrow. Histopathology 2013; 62; 397-405.